More Clinical Articles


Pay-for-Delay Deals could be Essential for More Generics and Cheaper Medicines

Anonymous, (Jul 24, 2013)

Limiting pay-for-delay deals will reduce pharmaceutical investment in generics and increase the cost of medicines for patients, states global economic consulting firm.

On Target – New Research Improves Drug Targeting

Lucy Brake, (Jul 23, 2013)

Scientists have developed a novel technique to provide more precise information about whether a drug has hit its target, ultimately making the drug development cycle less costly and more efficient.

Realizing the Potential of Stratified Medicines

Lucy Brake, (Jul 22, 2013)

A recent report from The Academy of Medical Sciences makes recommendations to address barriers to the widespread development and adoption of stratified medicine in the UK, in areas such as clinical development and pricing and reimbursement.

Research Develops Novel Drug Delivery System

Lucy Brake, (Jul 17, 2013)

Scientists at The University of Melbourne have developed an efficient system where tiny objects, such as bacterial cells, are coated with thin film membranes that assemble themselves.

More Approvals for Neglected Diseases but not R&D

Anonymous, (Jul 15, 2013)

Annual R&D spending for neglected diseases has been static since 2007 even though new research suggests that yearly approvals in this illness area have doubled in recent years.

Pfizer Continues Investment In Ireland

Lucy Brake, (Jul 15, 2013)

To support the development of new pharmaceuticals in Pfizer’s pipeline, the US company is investing US$130 million into Irish plants.

Nearly $8 Billion Profit Expected in NSCLC Market due to B-MS Blockbuster

Anonymous, (Jul 10, 2013)

Bristol Myers-Squibb’s (B-MS) nivolumab could expand the global non-small cancer cell lung cancer (NSCLC) market from $5.7 billion in 2012 to $7.9 billion in 2022.

New UK DNA Mapping Project Targets Cancer, Rare Diseases And Infectious Diseases

Lucy Brake, (Jul 9, 2013)

UK Health Secretary Jeremy Hunt has announced that the UK’s new DNA mapping project will focus its genetic analysis efforts on lung and children's cancer, rare diseases and infectious diseases.

Two Patients Remain HIV Free After Bone Marrow Transplant

Zuzanna Fimińska, (Jul 5, 2013)

Two HIV-positive patients who received bone marrow transplants to cure leukemia appear virus-free despite stopping treatment with antivirals, the researchers from the Brigham and Women’s Hospital in Boston announced Wednesday.

Improved Biotech Growth could also Encourage Further M&A Deals

Anonymous, (Jul 2, 2013)

A report indicating an expected £7.8 billion in revenue during 2013/2014 for the UK biotechnology industry could also signal the continued growth of pharmaceutical M&A deals.